000503 国新健康
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-9.623-33.478-0.734-7.486-11.265
总资产报酬率 ROA (%)-5.899-20.923-0.517-5.218-7.336
投入资产回报率 ROIC (%)-6.672-24.953-0.610-6.456-9.865

边际利润分析
销售毛利率 (%)-14.57021.21115.25624.83520.721
营业利润率 (%)-100.508-114.882-4.419-25.043-27.174
息税前利润/营业总收入 (%)-94.496-112.581-2.726-22.318-26.435
净利润/营业总收入 (%)-100.714-115.280-3.213-24.330-27.105

收益指标分析
经营活动净收益/利润总额(%)102.92237.5571,203.376147.605134.444
价值变动净收益/利润总额(%)-8.21658.642-1,277.389-50.714-22.166
营业外收支净额/利润总额(%)0.0110.328-34.869-5.437-1.619

偿债能力分析
流动比率 (X)3.0562.0313.0173.0072.000
速动比率 (X)3.0362.0203.0163.0042.000
资产负债率 (%)32.97743.99931.83127.16835.550
带息债务/全部投入资本 (%)20.65423.55611.43314.21612.029
股东权益/带息债务 (%)343.678286.940703.746602.815726.053
股东权益/负债合计 (%)203.242127.277214.161267.871180.886
利息保障倍数 (X)-15.691-42.026-4.952-15.563-86.230

营运能力分析
应收账款周转天数 (天)261.819139.736128.575139.147117.303
存货周转天数 (天)10.7354.6121.6531.4790.004